A study to determine reactogenicity of COVID-19 vaccines in different combinations at Helios Klinikum Hildesheim clinic
Latest Information Update: 18 Aug 2022
At a glance
- Drugs AZD 1222 (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Pharmacodynamics
- Acronyms HelCo-Vac Study
- 18 Aug 2022 New trial record
- 28 Jun 2022 Results presented at the 15th Congress of the European Association for Clinical Pharmacology and Therapeutics (EACPT) 2022